Regulatory News Briefs
This article was originally published in The Gray Sheet
Executive Summary
FDA schedules a workshop on non-microbial infection diagnostics, issues guidance on a category of molecular diagnostics and labels HeartWare's latest recall for its ventricular assist system as a class I action.